Healthy Skepticism International News

Upjohn Lincomycin (linconmycin) and Dalacin C (clindamycin)

November 1995

Vol 13 Issue 11 This Month: Upjohn's promotion of Lincocin (lincomycin) and Dalacin C (clindamycin) for upper respiratory tract infections in the Philippines. Follow up: Replies from Parke-Davis to our letter regarding promotion of Ponstan (mefenamic acid) for fever in children in Pakistan and from SmithKline Beecham to our letter regarding promotion of Ashton & Parsons Infants' Powders in the Gambia.

HS Int News index

Comments

Our members can see and make comments on this page.

Please
Click to Register

(read more)

then
Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts

If there is something you don't like, please tell us. If you like our work, please tell others.

Announcements

PharmedOut’s annual conference: Missing The Target: When Practitioners Harm More Than Heal

No Free Lunch is merging with Healthy Skepticism

Conference program: Pharma Knows Best? Managing Medical Knowledge

Prescrire’s proposals for France’s national conference on medicines policy

Pharmed Out Conference ‘Pharma Knows Best? Managing Medical Knowledge’

More announcements

What's new on this site

Next issue: SmithKline Beecham Halfan (halofantrine)

Previous issue: Parke-Davis Ponstan (mefenamic acid)

HS Int News index

There is no sin in being wrong. The sin is in our unwillingness to examine our own beliefs, and in believing that our authorities cannot be wrong. Far from creating cynics, such a story is likely to foster a healthy and creative skepticism, which is something quite different from cynicism.â€
- Neil Postman in The End of Education